Edap Tms (NASDAQ:EDAP) Price Target Cut to $10.00 by Analysts at HC Wainwright

Edap Tms (NASDAQ:EDAP) had its price target cut by HC Wainwright from $14.00 to $10.00 in a research note released on Thursday,Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.

Several other brokerages have also commented on EDAP. Weiss Ratings reissued a “sell (d-)” rating on shares of Edap Tms in a report on Monday, December 29th. Wall Street Zen lowered shares of Edap Tms from a “hold” rating to a “sell” rating in a report on Saturday, March 28th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Edap Tms currently has a consensus rating of “Hold” and a consensus target price of $6.00.

Edap Tms Price Performance

Shares of NASDAQ EDAP opened at $3.36 on Thursday. The firm has a market cap of $125.63 million, a PE ratio of -4.36 and a beta of -0.09. The firm has a fifty day moving average of $4.12 and a 200 day moving average of $3.22. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.19 and a current ratio of 1.54. Edap Tms has a one year low of $1.21 and a one year high of $5.05.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, March 25th. The medical equipment provider reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.09). The company had revenue of $22.22 million during the quarter, compared to analysts’ expectations of $21.28 million. Edap Tms had a negative return on equity of 100.07% and a negative net margin of 41.24%. As a group, research analysts predict that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

A number of large investors have recently modified their holdings of EDAP. Flax Pond Capital LLC purchased a new stake in shares of Edap Tms during the fourth quarter worth $2,623,000. Leonteq Securities AG acquired a new position in shares of Edap Tms during the 4th quarter valued at about $313,000. Rock Springs Capital Management LP boosted its position in shares of Edap Tms by 1.3% during the 4th quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock valued at $4,233,000 after acquiring an additional 16,500 shares during the last quarter. Kovack Advisors Inc. acquired a new position in shares of Edap Tms during the 4th quarter valued at about $53,000. Finally, Financial Planning Navigators CORP acquired a new position in shares of Edap Tms during the 4th quarter valued at about $33,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.